TNGX — Tango Therapeutics Inc. stock price and chart

Share this page

TNGX

$22.04-2.91%

as of close, Oct 16, 2026

☾ AH $22.04 -2.91%

Tango Therapeutics Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.007%US Stock Market 0.006%Russell 3000 0.005%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Sep 9, 2020

VolumeEEEE

20202022202320252026

5.010.015.020.025.030.0050.0M$22.04

2026-10-16

Price$22.04

MA20$25.32

MA50$21.89

Vol3.7M

What would $1,000 invested in TNGX be worth today? →

TNGX returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $22.04
YTD price return: +148.76%
YTD total return: +148.76%
Next earnings: Nov 3, 2026
Market cap: 3.7B2020-09 221.5M2026-10 3.7B+1578.7% over the window
Enterprise value: 2.7B
Shares outstanding: 168.6M2020-09 21.4M2026-06 168.6M+688.7% over the window
52W low: $6.69
52W high: $34.39
From 52W high: -35.91%
From 52W low: +229.45%
52W range: 55%

Volume

Rel volume: 1.04×
30D volume: 3.6M
30D $ vol: 82.9M

Fundamentals

Sales (ttm): 53.8M2020-12 7.7M2026-06 53.8M+602.9% over the window
Sales/share: $0.322020-12 $0.192026-06 $0.32+68.3% over the window
EPS (ttm): -$0.912021-06 -$1.082026-06 -$0.91-15.5% over the window
FCF (ttm): -144.3M2020-12 69M2026-06 -144.3M-309.2% over the window
FCF/share: -$0.862020-12 $1.712026-06 -$0.86-150.1% over the window
Book value/share: $6.082020-09 $2.192026-06 $6.08+176.9% over the window
Net margin: -229.92%2020-12 -678.8%2026-06 -229.9%-66.1% over the window
ROE: -12.08%2020-12 -134.6%2026-06 -12.1%-91.0% over the window
ROA: -11.52%2020-12 -25.1%2026-06 -11.5%-54.1% over the window
Current ratio: 50.822020-09 0.012026-06 50.82+360431.8% over the window

Growth (CAGR, ttm) · 10Y

Sales: +121.59%2025-06-30 → 2026-06-3024.3M → 53.8M (+121.5% total)+16.88%2023-06-30 → 2026-06-3033.7M → 53.8M (+59.7% total)+19.14%2021-06-30 → 2026-06-3022.4M → 53.8M (+140.0% total)n/a
Shares: +51.59%2025-06-30 → 2026-06-30111.3M → 168.6M (+51.5% total)+23.98%2023-06-30 → 2026-06-3088.5M → 168.6M (+90.6% total)+51.15%2021-06-30 → 2026-06-3021.4M → 168.6M (+688.7% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share: +46.18%2025-06-30 → 2026-06-30$0.22 → $0.32 (+46.1% total)-5.72%2023-06-30 → 2026-06-30$0.38 → $0.32 (-16.2% total)-21.18%2021-06-30 → 2026-06-30$1.05 → $0.32 (-69.6% total)n/a
Book value/share: +401.50%2025-06-30 → 2026-06-30$1.21 → $6.08 (+401.0% total)+36.15%2023-06-30 → 2026-06-30$2.41 → $6.08 (+152.4% total)+18.80%2021-06-30 → 2026-06-30$2.57 → $6.08 (+136.6% total)n/a
Price: +140.49%2025-10-16 → 2026-10-16$9.17 → $22.04 (+140.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+50.07%2023-10-16 → 2026-10-16$6.52 → $22.04 (+238.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+9.45%2021-10-15 → 2026-10-16$14.03 → $22.04 (+57.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: +140.49%2025-10-16 → 2026-10-16$9.17 → $22.04 (+140.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+50.07%2023-10-16 → 2026-10-16$6.52 → $22.04 (+238.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+9.45%2021-10-15 → 2026-10-16$14.03 → $22.04 (+57.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -24.2×2020-12 -8.892026-10 -30.05+238.2% over the window
Fwd P/E: -14.1×
P/S (ttm)Market cap ÷ TTM revenue.: 69.1×2020-12 60.332026-10 69.09+14.5% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 3.6×2020-09 4.722026-10 3.63-23.1% over the window
EV/Sales (ttm): 51.1×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -3.88%2020-12 14.9%2026-06 -2.7%-118.3% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 168.6M ÷ 111.3M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -51.59%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-51.59%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($569.7M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -51.59%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($3.7B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2020-12 0.0%2026-06 0.0%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($3.7B). Same caveat as the cash buyback yield.: 0.00%2020-12 0.0%2026-06 0.0%

Vs own 10Y history

P/S: 94th
P/B: 53rd

Bar = where today’s multiple sits in TNGX’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-2.91%

-7.43%

-5.61%

-20.26%

YTD

+148.76%

+140.35%

+57.09%

Financial statements

Open full TNGX financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

TNGX — Tango Therapeutics Inc. price, chart and key statistics